Stock HOLX HOLOGIC, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Hologic, Inc.

Equities

HOLX

US4364401012

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-15 pm EDT 		5-day change 1st Jan Change
77.54 USD +0.27% Intraday chart for Hologic, Inc. +0.21% +8.52%
Apr. 11 Bayer and Hologic Collaborates to Deliver Contrast-Enhanced Mammography CI
Apr. 09 Transcript : Hologic, Inc. Presents at 23rd Annual Needham Virtual Healthcare Conference, Apr-09-2024 11:45 AM

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Bayer and Hologic Collaborates to Deliver Contrast-Enhanced Mammography
CI
Hologic : to present at Needham Virtual Healthcare Conference Transcript
PU
Transcript : Hologic, Inc. Presents at 23rd Annual Needham Virtual Healthcare Conference, Apr-09-2024 11:45 AM
RBC Raises Price Target on Hologic to $81 From $76, Keeps Sector Perform Rating
MT
North American Morning Briefing : Focus Turns to -2-
DJ
Citigroup Upgrades Hologic to Buy From Neutral, Raises Price Target to $95 From $80
MT
Hologic to Announce Financial Results for the Second Quarter of Fiscal 2024 on Thursday, May 2, 2024
BU
Maverix Medical Closes Acquisition of Cirrus Bio as Foundation for Diagnostics Platform in Lung Cancer
AQ
Watching for Indications of a Changed Fed Outlook; Plus, How One Company Avoided Mass Layoffs
DJ
Hologic Insider Sold Shares Worth $1,241,296, According to a Recent SEC Filing
MT
Hologic : Annual Meeting of Stockholders Proxy
PU
Hologic, Inc. - Newly Published Results Reveal a Significant Proportion of Early-Stage HR+ Breast Cancer Survivors May Be Over or Undertreated Without Breast Cancer Index Genomic Testing
AQ
Hologic : to present at Raymond James' 45th Annual Institutional Investors Conference Transcript
PU
Newly Published Results Reveal a Significant Proportion of Early-Stage HR+ Breast Cancer Survivors May Be Over- or Undertreated Without Breast Cancer Index Genomic Testing
BU
Hologic, Inc. and Biotheranostics, Inc. Announces Newly Published Study Results Reveal That Use of the Breast Cancer Index®? Test
CI
Transcript : Hologic, Inc. Presents at 45th Annual Raymond James Institutional Investors Conference 2024, Mar-04-2024 08:40 AM
FDA warns of potential risk from Hologic's devices implanted in soft tissue
RE
FDA warns of potential risk of complications with use of Hologic's devices
RE
Hologic to Unveil Groundbreaking AI Research at ECR 2024
BU
Hologic to Webcast Presentations at Upcoming Investor Conferences
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HOLX Stock
  4. News Hologic, Inc.